Pdl Biopharma Inc (PDLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 116,334 | 76,145 | 26,007 | 189,660 | 161,100 |
| Depreciation Amortization | 6,962 | 4,723 | 2,416 | 4,406 | 2,615 |
| Income taxes - deferred | -5,679 | -3,230 | 277 | 10,242 | 888 |
| Accounts receivable | 800 | 900 | 900 | 12,450 | 13,100 |
| Accounts payable and accrued liabilities | 918 | -193 | 315 | -1,347 | -1,496 |
| Other Working Capital | 17,780 | 29,593 | -1,724 | -10,187 | -24,710 |
| Other Operating Activity | 17,198 | 15,689 | -1,255 | -18,270 | -18,693 |
| Operating Cash Flow | $154,313 | $123,627 | $26,936 | $186,954 | $132,804 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | N/A | 15,000 |
| PPE Investments | N/A | N/A | N/A | -39 | -39 |
| Purchase Of Investment | -28,810 | -12,402 | 0 | N/A | N/A |
| Sale Of Investment | 2,000 | N/A | 0 | 15,000 | N/A |
| Other Investing Activity | 0 | 0 | 0 | 3,469 | 3,469 |
| Investing Cash Flow | $-26,810 | $-12,402 | $0 | $18,430 | $18,430 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -180,682 | -150,751 | -12,621 | -69,953 | -69,953 |
| Common Stock Issued | N/A | N/A | N/A | 287,148 | 1,237 |
| Dividend Paid | -59,864 | -59,864 | -85 | -319,020 | -59,679 |
| Other Financing Activity | 10,302 | 7,475 | 2,217 | 70,610 | 70,521 |
| Financing Cash Flow | $-230,244 | $-203,140 | $-10,489 | $-31,215 | $-57,874 |
| Beginning Cash Position | 303,227 | 303,227 | 303,227 | 129,058 | 129,058 |
| End Cash Position | 200,486 | 211,312 | 319,674 | 303,227 | 222,418 |
| Net Cash Flow | $-102,741 | $-91,915 | $16,447 | $174,169 | $93,360 |
| Free Cash Flow | |||||
| Operating Cash Flow | 154,313 | 123,627 | 26,936 | 186,954 | 132,804 |
| Capital Expenditure | N/A | N/A | N/A | -39 | -39 |
| Free Cash Flow | 154,313 | 123,627 | 26,936 | 186,915 | 132,765 |